Keyphrases
Medications for Opioid Use Disorder
60%
Syringe Services Programs
49%
Opioid Use Disorder
46%
People Who Use Drugs
32%
Alcohol Use Disorder Treatment
32%
Medicaid Expansion
32%
Medicare Part D
32%
Kentucky
32%
Opioid Use Disorder Treatment
30%
COVID-19 Pandemic
30%
Opioid Treatment Programs
28%
Alcohol Use Disorder
26%
Access to Drugs
25%
Buprenorphine
24%
Treatment System
22%
Medicare
22%
Harm Reduction Services
22%
Medicare Beneficiaries
21%
Older Adults
20%
People Who Inject Drugs
20%
Program Implementation
20%
Overdose Deaths
19%
Substance Use Disorder Treatment
19%
County Level
17%
Medicaid Managed Care
16%
Counseling
16%
Treatment Termination
16%
Opioid Medication
16%
Prior Authorization
16%
Authorization Policy
16%
Service Needs
16%
Black Americans
16%
Trauma
16%
Access to Opioids
16%
Well-being
16%
Community-based Sample
16%
State Partisanship
16%
Rural Counties
16%
COVID-19 Pandemic Impact
16%
Prescribers
16%
High Threshold
16%
Substance Abuse Treatment
16%
Methadone Treatment
16%
Medicare Coverage
16%
Buprenorphine Treatment
16%
Injection Equipment Sharing
16%
Law Enforcement
16%
Injectable Naltrexone
14%
Substance Use Disorder
13%
Drug Testing
13%
Medicine and Dentistry
Drug Therapy
100%
Opioid Abuse
85%
Medicare
65%
Buprenorphine
58%
COVID-19
54%
Combination Therapy
44%
Opiate
39%
Harm Reduction
36%
Odds Ratio
23%
Infection
22%
Substance Use
19%
Client
18%
Drug Use
18%
Alcoholic Polyneuropathy
18%
Medicaid Managed Care
16%
COVID-19 Vaccination
16%
Alcohol Use Disorder
16%
CD20
16%
Methadone Treatment
16%
Multiple Sclerosis
16%
Autoimmune Disease
16%
T Cell
16%
Immune Response
16%
Attitude
16%
Substance Use Disorder
15%
Disease Modifying Therapy
14%
Counseling
13%
Drug Screening
10%
Naltrexone
10%
Intoxication
9%
Humoral Immunity
8%
Public Health
6%
T-Cell Response
6%
Serositis
5%
